Literature DB >> 10948097

Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains.

A Unkmeir1, H Schmidt.   

Abstract

The stx-flanking regions of 49 Shiga toxin-producing Escherichia coli strains and nine Shigella dysenteriae serotype 1 strains containing either stx, stx(1), stx(2), or stx(2) variant genes, were examined. We analyzed these regions by PCR using a set of primers with one primer specific for the respective stx gene and a second primer complementary to sequences of Stx phages H-19B and 933W. We further characterized the amplification products by restriction endonuclease digestion and nucleotide sequencing. PCR products of stx(1)-containing E. coli strains of serogroups O157, O26, and 0103 showed the same lengths and similar restriction patterns. However, we failed to amplify the 3' stx-flanking region in stx(1)-harboring E. coli O111:H(-) strains. Stx2-producing E. coli strains revealed amplification products of different lengths and restriction patterns, suggesting greater heterogeneity than in stx(1)-positive strains. We also obtained specific PCR products for two Stx2c-producing and seven Stx2f-producing E. coli strains when they were subjected to PCR analysis. In nine S. dysenteriae type 1 strains, H-19B- and 933W-specific primers amplified only the 3' stx-flanking region. The results of our study demonstrate that the stx genes of all strains investigated are continuous with phage sequences. Whereas almost all strains except E. coli O111:H(-) strains were associated with a S-like gene, association with Q could not be demonstrated in nine S. dysenteriae type 1 strains and three E. coli strains. Furthermore, we showed that the organization of the stx-flanking regions is similar in all strains investigated, whereas fine-structure analysis showed subtle differences among the sequences examined. Our results support the hypothesis that stx genes in E. coli and S. dysenteriae are generally phage-borne.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948097      PMCID: PMC101682          DOI: 10.1128/IAI.68.9.4856-4864.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Isogenic lysogens of diverse shiga toxin 2-encoding bacteriophages produce markedly different amounts of shiga toxin.

Authors:  P L Wagner; D W Acheson; M K Waldor
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2.

Authors:  P I Tarr; L S Fouser; A E Stapleton; R A Wilson; H H Kim; J C Vary; C R Clausen
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

3.  Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.

Authors:  M N Neely; D I Friedman
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

4.  Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children.

Authors:  T N Bokete; T S Whittam; R A Wilson; C R Clausen; C M O'Callahan; S L Moseley; T R Fritsche; P I Tarr
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

5.  An ileX tRNA gene is located close to the Shiga toxin II operon in enterohemorrhagic Escherichia coli O157 and non-O157 strains.

Authors:  H Schmidt; J Scheef; C Janetzki-Mittmann; M Datz; H Karch
Journal:  FEMS Microbiol Lett       Date:  1997-04-01       Impact factor: 2.742

6.  Identification of a clone of Escherichia coli O103:H2 as potential agent of hemolytic-uremic syndrome in France.

Authors:  P Mariani-Kurkdjian; E Denamur; A Milon; B Picard; H Cave; N Lambert-Zechovsky; C Loirat; P Goullet; P J Sansonetti; J Elion
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes.

Authors:  M Datz; C Janetzki-Mittmann; S Franke; F Gunzer; H Schmidt; H Karch
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

8.  Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe.

Authors:  A E Heuvelink; N C van de Kar; J F Meis; L A Monnens; W J Melchers
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality.

Authors:  H Schmidt; C Geitz; P I Tarr; M Frosch; H Karch
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

10.  Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome.

Authors:  H Rüssmann; E Kothe; H Schmidt; S Franke; D Harmsen; A Caprioli; H Karch
Journal:  J Med Microbiol       Date:  1995-06       Impact factor: 2.472

View more
  63 in total

1.  The nucleotide sequence of Shiga toxin (Stx) 2e-encoding phage phiP27 is not related to other Stx phage genomes, but the modular genetic structure is conserved.

Authors:  Jürgen Recktenwald; Herbert Schmidt
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Shigella dysenteriae type 1-specific bacteriophage from environmental waters in Bangladesh.

Authors:  Shah M Faruque; Nityananda Chowdhury; Rasel Khan; M Rubayet Hasan; Jebun Nahar; M Johirul Islam; Shinji Yamasaki; A N Ghosh; G Balakrish Nair; David A Sack
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

3.  Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak.

Authors:  Maite Muniesa; Mercè de Simon; Guillem Prats; Dolors Ferrer; Helena Pañella; Juan Jofre
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

4.  Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains.

Authors:  Shah M Faruque; Rasel Khan; M Kamruzzaman; Shinji Yamasaki; Q Shafi Ahmad; Tasnim Azim; G Balakrish Nair; Yoshifumi Takeda; David A Sack
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

5.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

6.  First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.

Authors:  Eckhard Strauch; Christoph Schaudinn; Lothar Beutin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Purification and characterization of the repressor of the shiga toxin-encoding bacteriophage 933W: DNA binding, gene regulation, and autocleavage.

Authors:  Astrid P Koudelka; Lisa A Hufnagel; Gerald B Koudelka
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

8.  The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression.

Authors:  Jessica S Tyler; Melissa J Mills; David I Friedman
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

9.  The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein.

Authors:  Kristina Creuzburg; Jürgen Recktenwald; Volker Kuhle; Sylvia Herold; Michael Hensel; Herbert Schmidt
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

10.  Induction of Shiga toxin-converting prophage in Escherichia coli by high hydrostatic pressure.

Authors:  Abram Aertsen; David Faster; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.